Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 May;67(5):502-8.
doi: 10.1111/j.1464-410x.1991.tb15195.x.

Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma

A V Kaisary  1 , C J Tyrrell, W B Peeling, K Griffiths
Affiliations
Clinical Trial

Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma

A V Kaisary et al. Br J Urol. 1991 May.

Erratum in

  • Br J Urol 1993 May;71(5):632

Abstract

Between November 1983 and February 1986, 358 patients with previously untreated metastatic prostatic carcinoma entered a multicentre, randomised trial in the United Kingdom and the Republic of Ireland, in which the LHRH analogue Zoladex (ICI Pharmaceuticals PLC), administered subcutaneously every 28 days, was compared with orchiectomy. Both treatments were equally effective in lowering serum testosterone concentrations to within the surgically castrate range and this was accompanied by equivalent subjective and objective response rates and times to treatment failure. At a median follow-up of 2 years there was no difference in overall survival, confirming that Zoladex is an effective medical alternative to orchiectomy in patients with metastatic disease.

PubMed Disclaimer

Comment in

LinkOut - more resources